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Proinflammatory Cytokines, Neurotrophie Factors, and Reactive 
Astrogiiosis during CNS Trauma 
L.M, Herx. V,W. Yong, University of Calgary, Canada 
278 
Site Specific Immune Regulation in the CNS Revealed by Low-dose 
IFN-gamma 
L. Phillips. P. Simon, L. Lampson, HarvardMedicalSchool, USA 
Following injury to the adult CNS, asla'ocytes become reactive and 
p,'aduce neurotrophic factors in what appears to be a failed attempt to promote 
recovery. Identification of the molecular mediators of this process known as 
astrogliosis is necessary in order to establish suitable conditions for axonal 
regeneration and remyelination. In a corticectomy model of injury in adult 
mice, proinflammatory cytokines 1L.I and TNF-0t mRNA levels become 
elevated within 1 hour as measured by RT-PCR. By in situ hybridization, IL-I 
is localized in a specific population of cells around the injury site and within 
the corpus eallosum. This elevation of proinflammatory c tokines precedes the 
rise in GFAP mRNA, the earliest discernible manifestation f astrogliosis, and 
the upregulation of neurotrophic factor transcripts uch as CNTF. Current 
expenmonts test the hypothesis that proinflammatory cytokines activate 
~trocytes to become reactive and influence their production of neurotrophic 
factors. 
Although neurotransmitters and neuropeptides are known to affect immune function 
in vitro, little is known about how the local mix of neurochemicals influences 
immune activity in the CNS. Using a novel model, we studied local modulation of the 
immune response. Specifically, T cell traffic and MHC expression were examined in 
two sites with very different neurochemical environments, the brain stem and 
hippocampus. The cytokine gamma interferon (IFN-g, 0.1 to 10,000 U / site) was 
injected stereotaxically into the hippocampus and contralateral brain stem of adult 
CDF rats. Two or four days later, monoclonal antibody staining was used to detect 
class I and 11 MHC proteins or T cells on cryostat sections, followed by quantitative 
computer-assisted image analysis. As compared to the hippocampus, the brain stem 
showed enhanced MHC expression by microglia t lower IFN-g doses, and reached a
higher plateau. Site-specific MHC modulation was also seen within the layers of the 
hippocampus, and among other brain sites. Moreover, different panems of T cell 
migration into the parenchyma were observed in the two CNS regions. Our 
preliminary data suggests that the local neuroregulatory environment, such as the 
high SP levels in the brain stem. contributes to this site-specific ontrol. These 
findings have implications for the therapeutic control of the immune response, and 
may help explain the localization of pathological neuro-immunc conditions uch as 
MS plaques. 
276 
Expression of the Anaphylatoxin C5a Receptor by Glial Cells and T 
Lymphocytes in Exper imental  Allergic Encephalomyelit is 
S, _Nataf, N. Davoust, S.R. Barnum, University ofAlabama atBirmingham, USA 
In this study, we investigated the expression of the C5aR in spinal cords of 
Lewis rots with experimental llergic encephalomyelitis (EAE). Using in situ 
hybridization (ISH) we analyzed the kinetics of C5aR expression at diffonmt 
time points of EAE (preclinicai stage, clinical peak, remission phase). While 
C5aR mRNA was constitutively exlxessod at variable low levels in neurons, 
some blood vessels and a subpopulation of astrocytes in liealthy control rats, it 
was readily detected in inflammatory cells invading the CNS at all the stages of 
EAE. Using a combination of ISH and immanohistochemistry we identifw, d 
multiple cell types expressing the CSaR in the CNS of EAE rats. Based on 
cell morphology the C5aR mRNA was localized in ~tivated microglial cells 
and rotmd EDl-positive cells corresponding to monocyte/macrophages. In 
addition, hypertrophic astroeytes strongly expressed both C5aR mRNA and 
GFAP particularly during disease remission. Smprisingly, C5aR InRNA was 
also detected in infiltrating T lymphocyte.s recognized by an anti-TCR 
antibody. The potential involvement ofC5a and its receptor in cell trafficking 
and activation of CNS immunocomoetent ceils is discussed. 
279 
Differential Effects of Interleukin-4 and Interlenkin-10 on ILl.13 
Induced Mouse Pr imary  AstroeyteAct ivaf ion Compar ison with 
Dexamethasone 
E Pousset, S. Crem ona, R. Dantzer, INSEI~ U.394, France, K. Kelley, Department 
of Animal Sciences, Urbana, USA, P. Darner, INSERM U.394, France 
The inflammatory cytokine lI.,-lO Is able to induce severe c¢lhttar br, un 
damage Diffetmat processes regulate IL-I biological activities, like the 
l~r~luc~on of antl-mflanmmtory c tokines, e.g IL-4 and IL-10. We describe 
here, the effects of IL-4 and IL-10 on 1L-l[3-indnced IL--6 prodtmuon m mou_.~ 
primary astrocytes and compare these effects to those of dexametl~ne. IL-6 
secretion and mRNA expte~ion were ~termm~d by E'LISA and RT-PCR 
restx~oJvely. S im~ux ~timlldariOn of ~ With IL-ll3+lI,-IO or I f .  
I[3~-dexamethaanne for 6 h mark~Jly redmmd IL-1,13 induced IL-6 secrelion 
mad EL~6 mRN'A exq3ression ~ve ly ,  whereas ilmlltaneo~ addition of IL- 
4 had no effect. In contrast, aRer 24 h of IL-I~ pretreatmem, ILM production 
wa~ deexe.axed belo~v consw.itutlve l vela, and this chang~ w-as xt.versed by 
addition of 1I.-4. The d~layed effect of IL-4 maght Ix: partially e.xplamcd by the 
in.duct]on of IL--4 re~e~or ct..~haln m]R~A ax~pr~on by IL-II~. We eoncllade 
that IL-tO and ~ r ,  olx¢: are rapid ildfibitors of IL,5 ha IL-I~ activated 
asrrocyres, whereas IL~, stimulates IL4; production. Th¢~e resdta suggest that 
I L4  and IL-10 play art essential role in the regulation the cerebral 
inflammatory esl~nSe. 
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Inhibit ion of I FN-gamma Induced Class I I  Transact ivator 
and Class I I  MHC Expression in Mierogl ia 
G.M. O'Keefe, E.N. Benveniste, University ofAlabama t BOTningham, USA 
Microglia are the brain's resident macrophage and when actvated have 
functions including cytokine production and antigen presentation. The class 
II genes in the major histocompatability complex (MIIC) locus encode 
proteins that present antigen to CD4+ T-cells, leading to their activation and 
the development of an antigen specific immune response. In microglia, class 
II MHC expression is upregulated by intefferon-T (IFN-y). Class I1 MHC 
gene expression is controlled by the class II transactivator (CIITA) 
transcription factor. IFN-y induced expression of the CIITA gene is 
controlled by one its four promoters (Promoter IV). In this study, we 
investigated the effects of TGF-1[31, IL-4, and IL-10 on WN-y induced class II 
MHC and CIITA expression. By FACS analysis, we show that IFN-y 
induced class II MHC protein expression is down-regulated by TGF-[~I, IL-4 
and IL-10. Using a RNase protection assay, we show that TGF-~I, IL-4 and 
IL-10 inhibit CIlTA mRNA and in turn class II MHC mRNA expression. 
Studies are ongoing to understand the moleculax mechanisms underlying the 
inhibitory effects of these cytokines. 
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Cell Type Specific Expression of  Tumor  Necrosis Factor-a in the CNS 
and Pitui tary of Transgenic Mice 
A. Seho~aeberg, E Heier, M. Klein, I. Pieri, Institute ofCellBiology andlmmunology, 
Univeraity of Stuttgart, Germany, J. Bauer, Clinical lnstitute of Neurology, University 
of Vienna, Austria, M.K.H. S chafer, Instttate of Anatomy and Cell Biology, University of 
Marburg, Germany, A. DelRey, K.H. Voigt, lns,tute of Normal andPathological 
Physiology, University ofMarburg, Germany, H. Lassmanll, Clinicat Inst~tute of
Neurology, University of Vienna, Austria, W. Wurst, Max P lanck lnstitute for Psychiatry, 
Munich, Germany, G. Kollias, Hellenic Paateur lnstitute, Athens, Greece, 
K. Pfizenm aier, U. Eisel, h~slitute ofCell Biology andlmmunology, University of 
Stuttgart, Germany 
Tumor necrosis fhctor-ot (TNF<t) plays a central role in infiananatory processes 
including those of autoimmune diseases of the CNS. To investigate cell type 
specific functions of TNF-ct in the CNS and in the pituitary we have cloned and 
characterized novel neuronal promoters (NMDAR subunits a2 and e3) and used 
these together with the engrailed-1 and ratPOMC promoter to generate 
transgenic and knock-in mice. Analyses of transgene expression and the resulting 
phenotypes are currently performed. A transgenic mouse line expressing routine 
TNF-ct under control of the ratPOMC promoter shows restricted transgene 
expression in the intermediate lobe of the pituitary resulting in CD3-positive 
cellular infiltration. Expression in the intermediate lobe can be upregulated by 
application of the dopamine antagonist HaloparidoL Adrenalectomy results in 
strong transgene xpression in the anterior lobe. These data demonstrate the 
neuronal and hormonal regulation of TNF-ot transgene expression i  the pituitary 
and the activation of the hypothalamus-pituitary-adrenal axis. In conclusion, the 
use of cell type specific promoters for targeting the expression of TNF-ot in 
defined cellular subsets opens an approach to investigate both local cytokine 
functions and systemic reactions thereo£ 
